Pulike Biological Engineering (603566) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.034x

Based on the latest financial reports, Pulike Biological Engineering (603566) has a cash flow conversion efficiency ratio of 0.034x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥87.38 Million ≈ $12.79 Million USD) by net assets (CN¥2.58 Billion ≈ $377.25 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see 603566 stock market capitalisation for the company's overall valuation and market capitalisation.

Pulike Biological Engineering - Cash Flow Conversion Efficiency Trend (2010–2024)

This chart illustrates how Pulike Biological Engineering's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Pulike Biological Engineering Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Pulike Biological Engineering ranked by their cash flow conversion efficiency. Explore how high is Pulike Biological Engineering's earnings quality to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Verra Mobility Corp NASDAQ:VRRM	0.255x
Cerus Corporation NASDAQ:CERS	-0.045x
Forus S.A SN:FORUS	0.130x
SEALSQ Corp NASDAQ:LAES	-0.055x
Oron Group Investments & Holdings Ltd TA:ORON	0.394x
Flushing Financial Corporation NASDAQ:FFIC	0.028x
Hunan Huasheng Co Ltd SHG:600156	0.086x
China Bicycle Co Holdings Ltd SHE:000017	-0.041x

Annual Cash Flow Conversion Efficiency for Pulike Biological Engineering (2010–2024)

The table below shows the annual cash flow conversion efficiency of Pulike Biological Engineering from 2010 to 2024. View Pulike Biological Engineering stock quote for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CN¥2.63 Billion ≈ $384.28 Million	CN¥268.79 Million ≈ $39.33 Million	0.102x	-1.41%
2023-12-31	CN¥2.72 Billion ≈ $398.59 Million	CN¥282.78 Million ≈ $41.38 Million	0.104x	+27.22%
2022-12-31	CN¥2.80 Billion ≈ $409.51 Million	CN¥228.36 Million ≈ $33.42 Million	0.082x	-30.87%
2021-12-31	CN¥1.80 Billion ≈ $263.46 Million	CN¥212.53 Million ≈ $31.10 Million	0.118x	-22.92%
2020-12-31	CN¥1.71 Billion ≈ $250.17 Million	CN¥261.83 Million ≈ $38.31 Million	0.153x	+81.24%
2019-12-31	CN¥1.66 Billion ≈ $242.62 Million	CN¥140.10 Million ≈ $20.50 Million	0.084x	+9.45%
2018-12-31	CN¥1.64 Billion ≈ $239.34 Million	CN¥126.27 Million ≈ $18.48 Million	0.077x	-14.02%
2017-12-31	CN¥1.57 Billion ≈ $229.57 Million	CN¥140.86 Million ≈ $20.61 Million	0.090x	-47.45%
2016-12-31	CN¥1.48 Billion ≈ $216.71 Million	CN¥253.03 Million ≈ $37.03 Million	0.171x	+22.12%
2015-12-31	CN¥1.34 Billion ≈ $195.68 Million	CN¥187.09 Million ≈ $27.38 Million	0.140x	-36.75%
2014-12-31	CN¥683.59 Million ≈ $100.03 Million	CN¥151.21 Million ≈ $22.13 Million	0.221x	-26.36%
2013-12-31	CN¥603.33 Million ≈ $88.29 Million	CN¥181.21 Million ≈ $26.52 Million	0.300x	-10.59%
2012-12-31	CN¥440.47 Million ≈ $64.45 Million	CN¥147.96 Million ≈ $21.65 Million	0.336x	-31.46%
2011-12-31	CN¥311.26 Million ≈ $45.55 Million	CN¥152.54 Million ≈ $22.32 Million	0.490x	+35.24%
2010-12-31	CN¥195.88 Million ≈ $28.66 Million	CN¥70.98 Million ≈ $10.39 Million	0.362x	--

About Pulike Biological Engineering

SHG:603566 China Biotechnology

Market Cap

$522.60 Million

CN¥3.57 Billion CNY

Market Cap Rank

#12209 Global

#3580 in China

Share Price

CN¥10.32

Change (1 day)

+0.29%

52-Week Range

CN¥9.78 - CN¥14.44

All Time High

CN¥34.10